Vectura Group plc – Strategy, SWOT and Corporate Finance Report
- Pages: 53
- Published: May 2017
- Report Code: 3FC8E5CF-5E21-44D1-89A5-4CD02CF8FEF9
Vectura Group plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Key Highlights
Vectura Group (Vectura or 'the group') is engaged in the development of pharmaceutical therapies for the treatment of airways-related diseases. The group operates in the UK, where it is headquartered in Wiltshire. Vectura employed 243 people as of March 31, 2015.
Scope
– Detailed information on Vectura Group plc required for business and competitor intelligence needs
– A study of the major internal and external factors affecting Vectura Group plc in the form of a SWOT analysis
– An in-depth view of the business model of Vectura Group plc including a breakdown and examination of key business segments
– Intelligence on Vectura Group plc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
– News about Vectura Group plc, such as business expansion, restructuring, and contract wins
– Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Vectura Group plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vectura Group plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Vectura Group plc's business structure, strategy and prospects.
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.